NO933237D0 - Absorbat av en hjelpestoffblanding og et ikke-fast virksomt stoff for fremstilling av legemiddelpreparater - Google Patents

Absorbat av en hjelpestoffblanding og et ikke-fast virksomt stoff for fremstilling av legemiddelpreparater

Info

Publication number
NO933237D0
NO933237D0 NO933237A NO933237A NO933237D0 NO 933237 D0 NO933237 D0 NO 933237D0 NO 933237 A NO933237 A NO 933237A NO 933237 A NO933237 A NO 933237A NO 933237 D0 NO933237 D0 NO 933237D0
Authority
NO
Norway
Prior art keywords
absorbate
manufacture
active substance
pharmaceutical preparations
solid active
Prior art date
Application number
NO933237A
Other languages
English (en)
Other versions
NO933237L (no
Inventor
Theophil Hornykiewytsch
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO933237D0 publication Critical patent/NO933237D0/no
Publication of NO933237L publication Critical patent/NO933237L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO933237A 1992-09-11 1993-09-10 Absorbat av en hjelpestoffblanding og et ikke-fast virksomt stoff for fremstilling av legemiddelpreparater NO933237L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4230371 1992-09-11

Publications (2)

Publication Number Publication Date
NO933237D0 true NO933237D0 (no) 1993-09-10
NO933237L NO933237L (no) 1994-03-14

Family

ID=6467712

Family Applications (1)

Application Number Title Priority Date Filing Date
NO933237A NO933237L (no) 1992-09-11 1993-09-10 Absorbat av en hjelpestoffblanding og et ikke-fast virksomt stoff for fremstilling av legemiddelpreparater

Country Status (13)

Country Link
EP (1) EP0587137A1 (no)
JP (1) JPH06192093A (no)
KR (1) KR940006583A (no)
AU (1) AU663000B2 (no)
CA (1) CA2105913A1 (no)
FI (1) FI933954L (no)
HU (1) HUT67577A (no)
IL (1) IL106953A0 (no)
MX (1) MX9305578A (no)
NO (1) NO933237L (no)
NZ (1) NZ248627A (no)
TW (1) TW222585B (no)
ZA (1) ZA936695B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ267002A (en) * 1993-06-04 1997-07-27 Warner Lambert Co Chewable cold/sinus relief preparation comprising antihistamine and decongestant in a carrier consisting of silicon dioxide
US5626878A (en) * 1995-01-10 1997-05-06 Warner Lambert Company Reduction of electrostatic forces between magnesium trisilicate adsorbates
ES2212667T3 (es) * 1998-12-18 2004-07-16 Abbott Laboratories Formulacion de liberacion controlada con divalproex sodico.
KR101352299B1 (ko) * 2004-06-28 2014-02-17 벨로시스 파마슈티컬스 에이/에스 액상 제형용 담체로서의 다공성 정제

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2879161A (en) * 1956-05-14 1959-03-24 American Cyanamid Co Stable dry powder compositions containing choline chloride and methods of preparing same
DE3409063A1 (de) * 1984-03-13 1985-09-19 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von fliessfaehigen cholinchlorid-kieselsaeure-pulvern
DE3924093A1 (de) * 1989-07-20 1991-02-07 Hoechst Ag N,n'-bis(alkoxy-alkyl)-pyridin-2,4-dicarbonsaeurediamide, verfahren zu deren herstellung sowie deren verwendung
DE4020570A1 (de) * 1990-06-28 1992-01-02 Hoechst Ag 2,4- und 2,5-substituierte pyridin-n-oxide, verfahren zu deren herstellung sowie deren verwendung
GB9025251D0 (en) * 1990-11-20 1991-01-02 Solomon Montague C Nifedipine dosage forms

Also Published As

Publication number Publication date
FI933954A0 (fi) 1993-09-09
KR940006583A (ko) 1994-04-25
NZ248627A (en) 1995-01-27
AU663000B2 (en) 1995-09-21
CA2105913A1 (en) 1994-03-12
ZA936695B (en) 1994-04-05
FI933954A7 (fi) 1994-03-12
TW222585B (no) 1994-04-21
IL106953A0 (en) 1993-12-28
MX9305578A (es) 1994-03-31
NO933237L (no) 1994-03-14
AU4626293A (en) 1994-03-17
HU9302555D0 (en) 1993-11-29
FI933954L (fi) 1994-03-12
JPH06192093A (ja) 1994-07-12
HUT67577A (en) 1995-04-28
EP0587137A1 (de) 1994-03-16

Similar Documents

Publication Publication Date Title
ATE468850T1 (de) Tramadolhaltiges arzneimittel mit gesteuerter wirkstoffabgabe
FI945198L (fi) Farmaseuttiset ja muut annosmuodot
FI955091L (fi) Parannetut farmaseuttisesti hyväksyttävät seokset, jotka sisältävät alkoholia ja hydrofobista lääkettä
NO171269C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive propenonoksimetere og mellomprodukter
NO882406D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive urinstoff- og karbamat-forbindelser.
NO914049L (no) Materialer som kan anvendes som saarbandasjer og for administrering av medikamenter
FI831998A0 (fi) Foerfarande foer framstaellning av farmaceutiskt aktiva pyrazinonderivat
DK287188A (da) Cephalosporinforbindelser og farmaceutisk praeparat deraf
FI904838A7 (fi) Menetelmä farmaseuttisesti aktiivisten karboksitetrahydroisokinoliinien ja niiden johdannaisten valmistamiseksi
NO173093C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive amidino-og guanidino-derivater
NO304890B1 (no) Farmas°ytiske forbindelser og farmas°ytiske preparater
NO151319C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive beta-mono-fluormetyl-beta-alanin- og beta-difluormetyl-beta-alanin-forbindelser
NO168644C (no) Fremgangsmaate for fremstilling av terapeutisk aktive n-(pyrrol-1-yl)pyridinaminer
FI920425A7 (fi) Sykloalkyleeniatsoleja, menetelmä niiden valmistamiseksi niitä sisältä viä farmaseuttisia valmisteita sekä niiden käyttö lääkeaineiden valmis tamiseen
DK269289A (da) Cyklopentanderivater og farmaceutiske praeparater indeholdende saadanne forbindelser
IT1231342B (it) Derivati peptidici farmacologicamente attivi e preparazioni farmaceutiche che li contengono
FI933954A7 (fi) Apuaineseoksesta ja ei-kiinteästä vaikuttavasta aineesta koostuva adsorbaatti lääkevalmisteiden valmistamiseksi
KR950700737A (ko) 기도 염증 및 기도 과잉반응의 치료약품(Medicament for the treatment of airways inflammation and airways hyperresponsiveness)
NO170086C (no) Fremgangsmaate for fremstilling av terapeutisk aktive 5-(omega-ammonio-acyloksy-metylen)-tetrahydrofuraner og -tetrahydrotiofener
HU910109D0 (en) Process for the production of medical preparations for preventing proline-and lysine-hydroxylase and process for the production of some of the active agents
FI940717A0 (fi) Streptogramiinien puhdistetut muodot, niiden valmistus ja niitä sisältävät farmaseuttiset valmisteet
NO172538C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 6-fenoksymetyl-4-hydroksytetrahydropyran-2-oner og 6-tiofen-oksymetyl-4-hydroksytetrahydropyran-2-oner
DE69117519D1 (de) 14-o-p-chlorbenzoylaconin und analgetischer/entzündungshemmender wirkstoff
FI962978A7 (fi) Kuivien lääkevalmisteiden valmistusmenetelmä ja näin saadut lääkeaines eokset
FI932768A7 (fi) Lysinkloniksinaattia sisältäviä farmaseuttisia pehmeitä kapseleita ja menetelmä niiden valmistamiseksi